3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Retinoblastoma
1
Retinal Neoplasms
1
Port-Wine Stain
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neoplasms
1
Hemangioma, Capillary
1
Eye Neoplasms
1
Interventions
Vincristine
5
Etoposide
5
Carboplatin
5
Melphalan
3
Topotecan
2
Platinum Compounds
2
Drug Therapy
2
Cyclophosphamide
2
Cryotherapy
2
pembrolizumab
1
omburtamab I-131
1
abemaciclib
1
Wechsler Scales
1
Watchful Waiting
1
Thiotepa
1
Surveys and Questionnaires
1
Specimen Handling
1
Observation
1
Microscopy, Acoustic
1
Memory and Learning Tests
1
Magnetic Resonance Spectroscopy
1
Lasers, Semiconductor
1
Lasers
1
LY2940680
1
Hyperthermia, Induced
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinoblastoma
×
Lasers
×
1 year
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled